Oxford Financial Statements From 2010 to 2024
| ONTTF Stock | USD 1.87 0.27 16.88% |
Check Oxford Nanopore financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oxford Nanopore's main balance sheet or income statement drivers, such as , as well as many indicators such as . Oxford financial statements analysis is a perfect complement when working with Oxford Nanopore Valuation or Volatility modules.
Oxford |
Oxford Nanopore Technologies Company Return On Equity Analysis
Oxford Nanopore's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Oxford Nanopore Return On Equity | -0.28 |
Most of Oxford Nanopore's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oxford Nanopore Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Oxford Nanopore Technologies has a Return On Equity of -0.2843. This is 98.81% lower than that of the Healthcare sector and 99.22% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 8.29% lower than that of the firm.
Oxford Nanopore Tech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oxford Nanopore's current stock value. Our valuation model uses many indicators to compare Oxford Nanopore value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oxford Nanopore competition to find correlations between indicators driving Oxford Nanopore's intrinsic value. More Info.Oxford Nanopore Technologies is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oxford Nanopore's earnings, one of the primary drivers of an investment's value.About Oxford Nanopore Financial Statements
Oxford Nanopore stakeholders use historical fundamental indicators, such as Oxford Nanopore's revenue or net income, to determine how well the company is positioned to perform in the future. Although Oxford Nanopore investors may analyze each financial statement separately, they are all interrelated. For example, changes in Oxford Nanopore's assets and liabilities are reflected in the revenues and expenses on Oxford Nanopore's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Oxford Nanopore Technologies. Please read more on our technical analysis and fundamental analysis pages.
Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom. Oxford Nanopore operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 900 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Oxford Pink Sheet
Oxford Nanopore financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Nanopore security.